Decrease lipoprotein improved glycemic control IDDM subjects OBJECTIVE lipoprotein Lp major risk factor coronary heart disease data available influence metabolic control plasma Lp concentrations subjects insulin-dependent diabetes IDDM group high risk coronary heart disease RESEARCH DESIGN AND METHODS effects improved metabolic control plasma lipid lipoproteins Lp concentrations subjects days tight metabolic control RESULTS Glycosylated hemoglobin Lp mg/dl significant differences total low-density lipoprotein high-density lipoprotein cholesterol decline triglyceride concentrations borderline significant distribution apolipoprotein isoforms IDDM patients unusual apolipoprotein isoform phenotypes change improved metabolic control Lp concentrations population-based control group nondiabetic subjects San Antonio Heart Study CONCLUSIONS number subjects small degree improvement metabolic control modest results improved metabolic control risk coronary heart disease Lp IDDM 